US Life Science patents to Australian assignees, last twelve months
The US Patent Office issues new patents every Tuesday. Australian assignees generally get two or three healthcare and biotech-related patents a week. Here are the 109 US patents relevant to Australia's Life Sciences sector that have issued since 29 December 2015, for an issuance rate of 2.1 per week.
US Patent 9,527,908 |
Title: Modified variable domain molecules and methods for producing them
Issued: 27 December 2016 Assignee: Garvan Institute of Medical Research |
Description: This patent antibody variable domains with aggregation-resistance properties.
|
US Patent 9,526,734 |
Description: This patent covers a dry-milled nanoparticle formulation of meloxicam.
|
US Patent 9,522,214 |
Title: Viscous haemostatic compositions and method of treatment
Issued: 20 December 2016 Assignee: Eupharma |
Description: This patent covers blood clotting drugs formulated as viscous thixotropic compositions.
|
US Patent 9,518,127 |
Title: Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
Issued: 13 December 2016 Assignee: CSL Ltd |
Description: This patent covers antibodies useful as anticoagulants.
|
US Patent 9,518,109 |
Title: Prevention, treatment and diagnosis of P. gingivalis infection
Issued: 13 December 2016 Assignee: Oral Health Australia Pty Ltd |
Description: This patent covers a vaccine against Porphyromonas gingivalis.
|
US Patent 9,518,089 |
Title: Metallothionein-derived peptide fragments
Issued: 13 December 2016 Assignee: University of Tasmania |
Description: This patent covers eptide fragments derived from metallothioneins that promote neuroregeneration.
|
US Patent 9,511,080 |
Description: This patent covers treatments related to Okadaella gastrococcus bacterial infection
|
US Patent 9,511,031 |
Description: This patent covers Mayne's controlled release formulation of doxycycline.
|
US Patent 9,511,017 |
Title: Method and composition for use in preparation of a patient for surgery
Issued: 6 December 2016 Assignee: Novapharm Research (Australia) Pty Ltd |
Description: This patent covers a transdermal biocide formulation.
|
US Patent 9,498,525 |
Description: This patent covers the use of killed Haemophilus influenzae in the treatment of asthma.
|
US Patent 9,492,552 |
Title: Injectable aqueous pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative
Issued: 15 November 2016 Assignee: Jurox Pty Ltd |
Description: This patent covers a use of cyclodextrins to increase the solubility of drugs.
|
US Patent 9,492,547 |
Description: This patent covers a new form of the polysaccharide inulin useful as a vaccine adjuvant.
|
US Patent 9,486,497 |
Title: Treatment of immunocompromised conditions
Issued: 8 November 2016 Assignee: University of Queensland |
Description: This patent covers the use of an E-selectin antagonist to treat hematopoietic disorders such as neutropenia.
|
US Patent 9,480,717 |
Title: Composition of whey growth factor extract for reducing muscle inflammation
Issued: 1 November 2016 Assignee: Murray Goulburn Co-Operative |
Description: This patent covers whey growth factor extract as an anti-inflammatory
|
US Patent 9,474,789 |
Title: Methods and compositions for promoting organ growth and development
Issued: 25 October 2016 Assignee: Kintan Pty Ltd |
Description: This patent covers the use of colony stimulating factor-1 protein (CSF-1) in promoting growth in premature-birthed warm blooded animals.
|
US Patent 9,474,270 |
Title: Methods and compositions for controlling pests
Issued: 4 October 2016 Assignee: Bioprospect and University of Western Sydney |
Description: This patent covers extracts from Eucalyptus cloeziana, commonly known as Gympie Messmate, useful in pest control.
|
US Patent 9,458,093 |
Title: Compositions for the treatment of hypertension and/or fibrosis
Issued: 4 October 2016 Assignee: Vectus Biosystems (ASX: VBS) |
Description: This patent covers the use of vasoactive intestinal peptide (VIP) fragment in treating fibrosis and hypertension.
|
US Patent 9,457,107 |
Title: Cage amine ligands for metallo-radiopharmaceuticals
Issued: 4 October 2016 Assignee: University of Melbourne |
Description: This patent covers metal-binding organic compounds that could be useful in radiotherapy.
|
US Patent 9,457,062 |
Description: This patent covers chaperonin 10 polypeptides, useful for activating Toll-Like Receptors.
|
US Patent 9,452,148 |
Title: Insulin sensitisers and methods of treatment
Issued: 27 September 2016 Assignee: Verva Pharmaceuticals |
Description: This patent covers carbonic anhydrase inhibitors for the treatment of insulin resistance.
|
US Patent 9,452,037 |
Description: This patent covers methods to deliver oral care products via magnetic disruption of the tissue barrier.
|
US Patent 9,447,080 |
Description: This patent covers small molecule inhibitors to the polymerase enzyme of Hepatitis C Virus.
|
US Patent 9,446,057 |
Description: This patent covers Mayne's controlled release formulation of doxycycline.
|
US Patent 9,441,239 |
Title: Methods and means for obtaining modified phenotypes
Issued: 13 September 2016 Assignee: Commonwealth Scientific and Industrial Research Organisation |
Description: This patent covers the CSIRO's gene silencing technology, which involves double-stranded RNA.
|
US Patent 9,440,926 |
Description: This patent covers antiviral compounds that target the p7 protein of HCV.
|
US Patent 9,439,946 |
Title: Reconstituted high density lipoprotein formulation and production method thereof
Issued: 13 September 2016 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers CSL's reconstituted HDL, useful for the treatment of Acute Coronary Syndrome.
|
US Patent 9,433,805 |
Title: Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition
Issued: 6 September 2016 Assignee: Ultraceuticals |
Description: This patent covers the use of glucomannan as a skin care product.
|
US Patent 9,428,587 |
Title: Antibodies to non-functional oligomeric P2X7 receptors and methods of use thereof
Issued: 30 August 2016 Assignee: Biosceptre International |
Description: This patent covers antibodies to P2X7 receptors which, when expressed on cells without their usual function ion channel function, is indicative of cancer cells.
|
US Patent 9,427,443 |
Description: This patent covers a formulation of the anesthetic alfaxalone that can be administered parenterally without invoking a histamine response.
|
US Patent 9,422,522 |
Title: Method of producing adipocytes from fibroblast cells
Issued: 23 August 2016 Assignee: Regenertech Pty Ltd (Dr Vishal Bhasin) |
Description: This patent covers a formulation which will prompt fibroblasts to differentiate into adipocytes.
|
US Patent 9,421,205 |
Description: This patent small molecule inhibitors of cancer target Focal Adhesion Kinase.
|
US Patent 9,415,063 |
Description: This patent covers a selenium formulation for the treatment of various brain disorders.
|
US Patent 9,408,919 |
Title: Biodegradable polymer-bioactive moiety conjugates
Issued: 9 August 2016 Assignee: PolyActiva Pty Ltd |
Description: This patent covers a drug-polymer conjugate with a better release profile than competing drug delivery polymers.
|
US Patent 9,408,824 |
Title: Compositions and products containing S-equol, and methods for their making
Issued: 9 August 2016 Assignee: Sanitarium (50%); Cincinnati Children's Hospital (United States, 50%) |
Description: This patent covers S-equol, an intestinally derived metabolite of the soy isoflavone daidzein. S-equol may be useful in enhancing the efficacy of soy diets.
|
US Patent 9,402,902 |
Title: Composition and method for the treatment and prevention of enteric bacterial infections
Issued: 2 August 2016 Assignee: Immuron (ASX: IMC) |
Description: This patent a vaccine for Gram negative bacteria made from cell wall antigens.
|
US Patent 9,402,896 |
Title: Method of inducing tolerance to an allergen
Issued: 2 August 2016 Assignee: Murdoch Childrens Research Institute |
Description: This patent covers the use of probiotics in the use of oral immunotherapy for peanut allergies.
|
US Patent 9,394,393 |
Title: Method for improving the stability of purified factor VIII after reconstitution
Issued: 19 July 2016 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers a Factor VIII molecule modified for improved stability by the inactivation of various proteolytic cleavage sites.
|
US Patent 9,393,287 |
Title: Methods and compositions for promoting organ development
Issued: 19 July 2016 Assignee: Kintan Pty Ltd |
Description: This patent covers the use of colony stimulating factor-1 protein (CSF-1) in promoting growth in premature-birthed warm blooded animals.
|
US Patent 9,393,274 |
Description: This patent covers the use of mixtures of Bacillus thuringiensis and related bacteria in the treatment of lice infestations in sheep.
|
US Patent 9,387,218 |
Title: Composition for the treatment of inflammatory and immune disorders
Issued: 12 July 2016 Assignee: Eaglepharma Pty Ltd (Paul Turner) |
Description: This patent covers an anti-inflammatory formulation of methylsulphonylmethane and glucosamine.
|
US Patent 9,387,213 |
Title: Small molecules inhibiting oncoprotein Myc
Issued: 12 July 2016 Assignee: Panacela Labs (part owned by Children's Cancer Institute Australia) |
Description: This patent covers a Myc inhibitor.
|
US Patent 9,381,262 |
Title: Methods for radiolabeling synthetic polymers
Issued: 5 July 2016 Assignee: Australian National University |
Description: This patent covers a radiolabeled polymer useful in brachytherapy.
|
US Patent 9,381,240 |
Title: Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors
Issued: 5 July 2016 Assignee: The Queensland Department of Agriculture and Fisheries (50%) and Meat & Livestock Australia (50%) |
Description: This patent covers a bovine viral diarrhea virus.
|
US Patent 9,376,682 |
Title: Method of treating pulmonary disease by administering an antibody to G-CSF
Issued: 28 June 2016 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers an antibody to G-CSF, useful for treating the neutrophil infiltration associated with COPD.
|
US Patent 9,365,829 |
Title: Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
Issued: 14 June 2016 Assignee: University of Technology, Sydney |
Description: This patent covers a technology to engineer insulin-secreting human liver cell line.
|
US Patent 9,365,650 |
Description: This patent covers an antibody-based anticoagulant agent.
|
US Patent 9,364,570 |
Title: Functionalisation of cage amine ligands for metallo-radiopharmaceuticals
Issued: 14 June 2016 Assignee: University of Melbourne |
Description: This patent covers metal-binding organic compounds that could be useful in radiotherapy.
|
US Patent 9,364,534 |
Description: This patent covers the use of anti-GSF receptor antibodies in the treatment of Multiple Sclerosis.
|
US Patent 9,359,422 |
Title: Single chain relaxin polypeptides
Issued: 7 June 2016 Assignee: University of Queensland (50%), Florey Institute of Neuroscience and Mental Health (50%) |
Description: This patent covers analogues of relaxin-3, potentially useful in the treatment of addictions.
|
US Patent 9,359,377 |
Title: Substituted imidazo[1,2-a]imidazo[4',5':4,5]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
Issued: 7 June 2016 Assignee: Biota |
Description: This patent covers direct-acting anti-virals for Respiratory Syncytial Virus.
|
US Patent 9,358,247 |
Title: Methods and compositions for promoting activity of anti-cancer therapies
Issued: 7 June 2016 Assignee: ORIL |
Description: This patent covers the use of saponins in the treatment of cancer.
|
US Patent 9,353,152 |
Title: Induction of the mitochondrial permeability transition
Issued: 31 May 2016 Assignee: University of New South Wales |
Description: This patent covers methods to identify compounds which will induce apoptosis in cancer cells through breaking open the inner mitochondrial membrane.
|
US Patent 9,352,038 |
Description: This patent covers the use of anti-GSF receptor antibodies in the treatment of Multiple Sclerosis.
|
US Patent 9,352,034 |
Title: Methods of treating pain using an antibody specific for GM-CSF
Issued: 31 May 2016 Assignee: University of Melbourne |
Description: This patent covers antibodies to GM-CSF in the treatment of pain.
|
US Patent 9,351,977 |
Title: Methods of reducing mammographic breast density and/or breast cancer risk
Issued: 31 May 2016 Assignee: Chavah Pty Ltd |
Description: This patent covers the use of testosterone and anastrozole to reduce mammographic breast density, improving the ability to detect breast cancer with mammograms.
|
US Patent 9,345,911 |
Title: Methods of inducing melanogenesis in a subject
Issued: 24 May 2016 Assignee: Clinuvel Pharmaceuticals (ASX: CUV) |
Description: This patent covers the use of alpha-MSH analogues to induce melanogenesis.
|
US Patent 9,345,667 |
Title: Particles having hydrophobic material therein
Issued: 24 May 2016 Assignee: Australian Nuclear Science & Technology Organisation |
Description: This patent covers a method for packaging hydrophobic molecules for timed delivery.
|
US Patent 9,340,622 |
Title: Synthetic immunogen useful for generating long lasting immunity and protection against pathogens
Issued: 17 May 2016 Assignee: University of Melbourne (50%), Council of Scientific and Industrial Research (India, 50%) |
Description: This patent covers a tuberculosis peptide vaccine which combines promiscuous epitopes from M. tuberculosis linked to a TLR ligand.
|
US Patent 9,340,583 |
Description: This patent covers the use of vasoactive intestinal peptide (VIP) fragment in treating fibrosis and hypertension.
|
US Patent 9,340,517 |
Title: Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor
Issued: 17 May 2016 Assignee: Mimetica Pty Ltd |
Description: This patent covers small molecules to modulate the melanocortin-5 receptor, useful in the treatment of skin disorders.
|
US Patent 9,326,539 |
Title: Compositions comprising dietary fat complexers and methods for their use
Issued: 3 May 2016 Assignee: Soho Flordis International |
Description: This patent covers alpha-cyclodextrin, which as a food ingredient can prevents fat absorption.
|
US Patent 9,320,755 |
Title: Therapeutic and diagnostic molecules
Issued: 26 April 2016 Assignee: Centenary Institute (33%), University of Sydney (33%) Wenkart Foundation (33%) |
Description: This patent covers an anti-angiogenesis microRNA.
|
US Patent 9,315,581 |
Title: Immuno-conjugates and methods for producing them
Issued: 19 April 2016 Assignee: Avipep Pty Ltd |
Description: This patent covers binding sites on antibodies for antibody-drug-conjugates.
|
US Patent 9,314,527 |
Description: This patent covers a Vitamin E-based transdermal drug delivery system inside a polymer carrier.
|
US Patent 9,314,450 |
Description: This patent covers the combination of irbesartan and propagermanium in the treatment of kidney disease.
|
US Patent 9,308,193 |
Title: Kinase inhibitors for the treatment of cancer
Issued: 12 April 2016 Assignee: PharmAust (ASX: PAA) |
Description: This patent covers the use of the anthelmintic agent Monepantel in the treatment of cancer.
|
US Patent 9,303,026 |
Description: This patent covers small molecules for the treatment of picornavirus infections.
|
US Patent 9,302,993 |
Description: This patent covers a suite of metal-protein attenuating compounds useful in treating Alzheimer's.
|
US Patent 9,299,476 |
Description: This patent covers conductive polymer, useful as an interface between a metal electrode and biological tissue.
|
US Patent 9,295,654 |
Title: Layered nanoparticles
Issued: 29 March 2016 Assignee: Australian Nuclear Science & Technology Organisation |
Description: This patent covers core-shell ceramic nanoparticles for drug delivery.
|
US Patent 9,295,652 |
Description: This patent covers an enteric-coated doxycycline formulation.
|
US Patent 9,295,628 |
Description: This patent covers casein phosphopeptide formulations used for the prevention of tooth decay.
|
US Patent 9,290,577 |
Title: Immuno-conjugates and methods for producing them
Issued: 22 March 2016 Assignee: Avipep Pty Ltd |
Description: This patent covers antibody-drug conjugates.
|
US Patent 9,289,586 |
Description: This patent covers a delivery device for transdermally-delivered drugs.
|
US Patent 9,289,410 |
Description: This patent covers an anti-cancer agents derived from the blushwood tree (Hylandia Dockrillii).
|
US Patent 9,289,381 |
Title: Stabilization and storage of biological pharmaceutical compositions
Issued: 22 March 2016 Assignee: Monash University (33%), The University of North Carolina at Charlotte (US, 33%), Charlotte-Mecklenburg Hospital Authority (US, 33%) |
Description: This patent covers a liquid called choline dihydrogen phosphate for the delivery of recombinant human interleukin-2.
|
US Patent 9,283,365 |
Description: This patent covers a method of coating bioactives onto projections from a patch.
|
US Patent 9,283,291 |
Title: Methods for radiolabeling macromolecules
Issued: 15 March 2016 Assignee: Australian National University |
Description: This patent covers a new method of radiolabelling proteins that involves managing through pH the repulsive electrostatic forces that would ordinarily push radiolabel and protein apart.
|
US Patent 9,283,212 |
Title: Pharmaceutical preparation and delivery system
Issued: 15 March 2016 Assignee: Palmaya Pty Ltd (Dr George O'Neil) |
Description: This patent covers subcutaneous implants of flumazenil for the treatment of addictions.
|
US Patent 9,278,134 |
Title: Dual functioning ionic liquids and salts thereof
Issued: 8 March 2016 Assignee: Monash University (33%), University of Alabama (US, 33%), Queen's University Belfast (UK, 33%) |
Description: This patent covers ionic liquids useful in pharmaceutical formulations.
|
US Patent 9,273,125 |
Title: Human monoclonal antibody having fat-reducing effect
Issued: 1 March 2016 Assignee: Patrys (ASX: PAB) |
Description: This patent covers antibodies to LDL cholesterol.
|
US Patent 9,272,046 |
Title: Itraconazole compositions and dosage forms, and methods of using the same
Issued: 1 March 2016 Assignee: Mayne Pharma (ASX: MYX) |
Description: This patent covers a new formulation of the antifungal drug itraconazole.
|
US Patent 9,271,982 |
Title: Animal feed supplement comprising ractopamine and caffeine
Issued: 1 March 2016 Assignee: Rivalea |
Description: This patent covers a combination of ractipamine, a beta adrenergic agonist, and caffeine to improve feed conversion rates in pigs.
|
US Patent 9,271,503 |
Description: This patent covers compounds from Clitoria ternatea to control insect pests relevant to the cotton industry.
|
US Patent 9,268,908 |
Description: This patent covers software to analyse cell counts as a way to track immune system cycles for optimal chemotherapy.
|
US Patent 9,266,864 |
Description: This patent covers small molecule antagonists to VEGFR3.
|
US Patent 9,265,817 |
Title: PAT-LM1 epitopes and methods for using same
Issued: 23 February 2016 Assignee: Patrys (ASX: PAB) |
Description: This patent covers the target for PAT-LM1, a monoclonal antibody relevant in haematological malignancies, including lymphomas.
|
US Patent 9,265,726 |
Description: This patent covers a foamable gel for topical drug delivery.
|
US Patent 9,265,249 |
Title: Dispersants in high-electrolyte solutions
Issued: 23 February 2016 Assignee: Huntsman Corporation Australia |
Description: This patent covers polyaminoamide resins to disperse water-insoluble actives in an aqueous solution.
|
US Patent 9,260,691 |
Title: Methods relating to an attenuated mycoplasma
Issued: 16 February 2016 Assignee: Bioproperties Pty Ltd |
Description: This patent covers the generation of attenuated Mycoplasma hyopneumoniae for use in porcine vaccines
|
US Patent 9,260,526 |
Title: Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
Issued: 16 February 2016 Assignee: Opthea (ASX: OPT) |
Description: This patent covers the cancer target VEGFR-3 as well as antibodies to it.
|
US Patent 9,254,288 |
Title: Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
Issued: 9 February 2016 Assignee: Queensland University of Technology (50%), The Translational Genomics Research Institute (US, 50%) |
Description: This patent covers variants of the tyrosine kinase protein FGFR2, known to be relevant in cancer drug resistance
|
US Patent 9,247,766 |
Title: Angiogenin-enriched milk fractions
Issued: 2 February 2016 Assignee: Murray Goulburn Co-Operative (50%), Agriculture Victoria Services (50%) |
Description: This patent covers milk enriched for angiogenin, a peptide with anti-inflammatory and anti-microbial properties.
|
US Patent 9,243,066 |
Title: Use of M-CSF antibodies in the treatment of osteoarthritis or pain
Issued: 26 January 2016 Assignee: University of Melbourne (50%), MorphoSys (Germany, 50%) |
Description: This patent covers antibodies for M-CSF, a hematopoietic growth factor, useful in the treatment of osteoarthritis.
|
US Patent 9,243,061 |
Description: This patent covers antibodies to GM-CSF, useful in tghe treatment of osteoarthritis, as well as GM-CSF knock-out mice.
|
US Patent 9,242,007 |
Title: Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
Issued: 26 January 2016 Assignee: EnGeneIC |
Description: This patent covers bacterially derived 'minicells' containing functional nucleic acids for use in cancer treatment
|
US Patent 9,241,952 |
Title: Method of treating type II diabetes, hyperglycemia or hypoglycemia by administering a synergistic combination of a sulphonylurea and inulin
Issued: 26 January 2016 Assignee: OzStar Therapeutics |
Description: This patent covers a combination of the naturally occurring polysaccharide called inulin and a sulphonylurea in the treatment of Type II Diabetes.
|
US Patent 9,241,883 |
Description: This patent covers casein phosphopeptide formulations.
|
US Patent 9,239,904 |
Description: This patent covers software to analyse cell counts as a way to track immune system cycles for optimal chemotherapy.
|
US Patent 9,238,644 |
Description: This patent covers small molecule antagonists to VEGFR3.
|
US Patent 9,238,054 |
Title: Treatment of kidney fibrosis with VIP fragments
Issued: 19 January 2016 Assignee: Vectus Biosystems (ASX: VBS) |
Description: This patent covers the vasoactive intestinal peptide in the treatment of kidney disease.
|
US Patent 9,238,001 |
Title: Delivery system for remote treatment of an animal
Issued: 19 January 2016 Assignee: Smartvet Pty Ltd |
Description: This patent covers a gun to deliver doses to an animal remotely.
|
US Patent 9,234,019 |
Description: This patent covers chaperonin 10 polypeptides, useful for activating Toll-Like Receptors.
|
US Patent 9,226,939 |
Description: This patent covers polyanions to combat the cytotoxic effects of extracellular histones in diseases such as sepsis.
|
US Patent 9,221,799 |
Description: This patent covers analogus of the marine alkaloid naamidine A, which is an antagonist of the Epidermal Growth Factor Receptor.
|
US Patent 9,220,928 |
Title: Plant extracts from Acronychia species and their use
Issued: 29 December 2015 Assignee: EcoBiotics |
Description: This patent covers natural products derived from a rainforest treet native to north Queensland called the lemon aspen (Acronychia acidula).
|
US Patent 9,220,806 |
Title: Biocompatible material and uses thereof
Issued: 29 December 2015 Assignee: University of Sydney |
Description: This patent covers a biocompatible ceramic made of doped calcium zinc silicate and a metal oxide useful in tissue regeneration.
|
US Patent 9,220,724 |
Title: MicroRNA-based approach to treating malignant pleural mesothelioma
Issued: 29 December 2015 Assignee: Asbestos Diseases Research Institute |
Description: This patent covers microRNA mimics, corresponding to the miR-15/107 family potentially useful in the treatment of mesothelioma.
|
US Patent 9,220,678 |
Description: This patent covers a method of coating bioactives onto projections from a patch.
|
Copyright © 2016 NDF Research
